LBEC0101, A Proposed Etanercept Biosimilar: Pharmacokinetics, Immunogenicity, and Tolerability Profiles Compared with a Reference Biologic Product in Healthy Male Subjects
Crossref DOI link: https://doi.org/10.1007/s40259-017-0230-9
Published Online: 2017-05-27
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lee, Heechan
Chung, Hyewon
Lee, SeungHwan
Lee, Howard
Yang, Sung Mo
Yoon, Seo Hyun
Cho, Joo-Youn
Jang, In-Jin
Yu, Kyung-Sang
Funding for this research was provided by:
LG Chem, Ltd., Republic of Korea (former LG Life Sciences, Ltd.)
License valid from 2017-05-27